Design Therapeutics, Inc. - DSGN

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 18
Latest filed: Apr 01, 2026
Form Count
4 7
8-K 4
SCHEDULE 13D/A 3
144 3
SCHEDULE 13G/A 1

Latest files

Filed Form Report period Accession SEC
Apr 01, 2026 4 Mar 31, 2026 0001559570-26-000006 View
Apr 01, 2026 8-K Mar 31, 2026 0001193125-26-137861 View
Mar 11, 2026 SCHEDULE 13D/A 0001072613-26-000257 View
Mar 09, 2026 8-K Mar 09, 2026 0001193125-26-098474 View
Feb 17, 2026 SCHEDULE 13G/A 0000902664-26-001131 View
Jan 30, 2026 8-K Jan 29, 2026 0001193125-26-031772 View
Jan 05, 2026 4 Jan 02, 2026 0001580787-26-000002 View
Jan 05, 2026 4 Jan 02, 2026 0001754129-26-000002 View
Jan 05, 2026 4 Jan 02, 2026 0001883722-26-000002 View
Jan 05, 2026 4 Jan 02, 2026 0001848377-26-000002 View
Jan 05, 2026 4 Jan 02, 2026 0001674703-26-000002 View
Dec 11, 2025 4 Dec 09, 2025 0001580787-25-000006 View
Nov 18, 2025 SCHEDULE 13D/A 0000935836-25-000710 View
Nov 18, 2025 144 0001178937-25-000065 View
Nov 14, 2025 144 0001178937-25-000060 View
Nov 12, 2025 SCHEDULE 13D/A 0000935836-25-000657 View
Nov 07, 2025 144 0001178937-25-000059 View
Nov 05, 2025 8-K Nov 05, 2025 0001193125-25-266933 View